Inventor
BOSANAC TODD
US29 patents
⚠️ This page may combine multiple inventors who share the name “BOSANAC TODD”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
DISARM THERAPEUTICS INC
9 patentsUS12083114B2Sep 10, 2024
Inhibitors of SARM1 in combination with neuro-protective agents
DISARM THERAPEUTICS INC5 citations70
US12441719B2Oct 14, 2025
Inhibitors of SARM1
DISARM THERAPEUTICS INC0 citations59
US12595481B2Apr 7, 2026
Methods and compositions for neuroprotection
DISARM THERAPEUTICS INC0 citations58
US12448374B2Oct 21, 2025
Inhibitors of SARM1
DISARM THERAPEUTICS INC0 citations58
US12435084B2Oct 7, 2025
Indazole derivatives as inhibitors of SARM1
DISARM THERAPEUTICS INC0 citations58
US12338238B2Jun 24, 2025
Inhibitors of SARM1
DISARM THERAPEUTICS INC0 citations58
US12331033B2Jun 17, 2025
Inhibitors of SARM1
DISARM THERAPEUTICS INC0 citations55
US12043613B2Jul 23, 2024
Inhibitors of SARM1
DISARM THERAPEUTICS INC0 citations47
US12595252B2Apr 7, 2026
Inhibitors of SARM1
DISARM THERAPEUTICS INC0 citations45
BOEHRINGER INGELHEIM INT
6 patentsUS10875852B2Dec 29, 2020
Heteroaromatic compounds as BTK inhibitors
BOEHRINGER INGELHEIM INT2 citations71
US10364255B2Jul 30, 2019
Heteroaromatic compounds as Vanin inhibitors
BOEHRINGER INGELHEIM INT6 citations71
US10138229B2Nov 27, 2018
Heteroaromatic compounds as BTK inhibitors
BOEHRINGER INGELHEIM INT2 citations71
US9975882B2May 22, 2018
Heteroaromatic compounds as BTK inhibitors
BOEHRINGER INGELHEIM INT5 citations68
US10570118B2Feb 25, 2020
Isoquinolones as BTK inhibitors
BOEHRINGER INGELHEIM INT1 citations59
US9828364B2Nov 28, 2017
Pyrazole compounds as BTK inhibitors
BOEHRINGER INGELHEIM INT0 citations39
BOSANAC TODD
5 patentsUS8809326B2Aug 19, 2014
Isoquinolinone Rho kinase inhibitors
BOSANAC TODD40 citations90
US8940893B2Jan 27, 2015
Heteroaromatic compounds as BTK inhibitors
BOSANAC TODD19 citations82
US8618300B2Dec 31, 2013
Indolizine inhibitors of leukotriene production
BOSANAC TODD2 citations60
US8815857B2Aug 26, 2014
Soluble guanylate cyclase activators
BOSANAC TODD1 citations48
US8895750B2Nov 25, 2014
Heteroaromatic compounds as BTK inhibitors
BOSANAC TODD0 citations39
BARTOLOZZI ALESSANDRA
4 patentsUS8580829B2Nov 12, 2013
Oxadiazole inhibitors of leukotriene production
BARTOLOZZI ALESSANDRA8 citations82
US8658661B2Feb 25, 2014
Oxadiazole inhibitors of leukotriene production
BARTOLOZZI ALESSANDRA3 citations61
US8575201B2Nov 5, 2013
Oxadiazole inhibitors of leukotriene production
BARTOLOZZI ALESSANDRA1 citations49
US8580825B2Nov 12, 2013
Oxadiazole inhibitors of leukotriene production
BARTOLOZZI ALESSANDRA0 citations40
ALKERMES PHARMA IRELAND LTD
3 patentsUS10975099B2Apr 13, 2021
Thiophene compounds for long-acting injectable compositions and related methods
ALKERMES PHARMA IRELAND LTD0 citations60
US10807995B2Oct 20, 2020
Thienothiophene compounds for long-acting injectable compositions and related methods
ALKERMES PHARMA IRELAND LTD0 citations50
US10799496B2Oct 13, 2020
Naphthylenyl compounds for long-acting injectable compositions and related methods
ALKERMES PHARMA IRELAND LTD0 citations50